API CAS 126784-99-4 Ulipristal Acetate Purity Ulipristal Acetate Powder Raw Materials Ulipristal Acetate
China API CAS 126784-99-4 Ulipristal Acetate Purity Ulipristal Acetate Powder Raw Materials Ulipristal Acetate, Find details about China Ulipristal Acetate, Ulipristal Acetate Powder from API CAS 126784-99-4 Ulipristal Acetate Purity Ulipristal Acetate Powder Raw Materials Ulipristal Acetate
Basic Info.
Model NO.
D-sung Ulipristal Acetate
Product Name
Ulipristal Acetate
Name
Ulipristal Acetate Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical;
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
126784-99-4
Mf
C30h37no4
MW
475.629
Boiling Point
640.1 °c At760mmhg
Density
1.19
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Model NO.
D-sung Ulipristal Acetate
Product Name
Ulipristal Acetate
Name
Ulipristal Acetate Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical;
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
126784-99-4
Mf
C30h37no4
MW
475.629
Boiling Point
640.1 °c At760mmhg
Density
1.19
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Product Desciption
API CAS 126784-99-4 Ulipristal Acetate Purity Ulipristal Acetate Powder Raw Materials Ulipristal Acetate
| Product name | Ulipristal Acetate |
| Appearance | White powder |
| CAS NO. | 126784-99-4 |
| MF | C30H37NO4 |
| MW | 475.629 |
| Boiling point | 640.1 °C at760mmHg |
Ulipristal acetate (UPA) is a selective progesterone receptor modulator. Attributing to its higher efficacy and a similar rate of side effects compared to levonorgestrel emergency contraception, it is now recommended as first line treatment for emergency contraception. Emergency contraception is defined as the use of drug or device after unprotected or under-protected intercourse to prevent an unwanted pregnancy. Ulipristal acetate can be used up to 5 days (120 h) after unprotected sexual intercourse.
As progesterone promotes the growth of uterine fibroids, the blocking characteristic of ulipristal acetate can thereby be used to reduce the size of uterine fibroids. Ulipristal acetate has also shown efficacy with a significant reduction in uterine bleeding caused by uterine fibroids. The treatment of fibroids by ulipristal acetate should begin in the first week of a menstrual period.
1.Ulipristalacetate is a progesterone agonist/antagonist whose mechanism of action is inhibition or delayed ovulation.
2.Endometrial changes, however, may also is one of the causes of curative effect of acetic acid uri department he belongs to selective progesterone receptor modulators, part of progesterone receptor antagonist and exciting role it and progesterone receptors in the human body to prevent the combination of progesterone and Chemicalbook progesterone receptor acetate uri department his effectiveness depends on the delivery time in the menstrual cycle in the middle of the follicular hyperplasia drug would inhibit ovarian follicles generation and reduce the concentration of estradiol in the periods of peak luteinizing hormone drug can make the follicle delayed crack 5 ~ 9 days
Early luteal administration did not significantly delay endometrial maturation, but reduced endometrial thickness by 0.62.2 mm(mean SD)
As progesterone promotes the growth of uterine fibroids, the blocking characteristic of ulipristal acetate can thereby be used to reduce the size of uterine fibroids. Ulipristal acetate has also shown efficacy with a significant reduction in uterine bleeding caused by uterine fibroids. The treatment of fibroids by ulipristal acetate should begin in the first week of a menstrual period.
1.Ulipristalacetate is a progesterone agonist/antagonist whose mechanism of action is inhibition or delayed ovulation.2.Endometrial changes, however, may also is one of the causes of curative effect of acetic acid uri department he belongs to selective progesterone receptor modulators, part of progesterone receptor antagonist and exciting role it and progesterone receptors in the human body to prevent the combination of progesterone and Chemicalbook progesterone receptor acetate uri department his effectiveness depends on the delivery time in the menstrual cycle in the middle of the follicular hyperplasia drug would inhibit ovarian follicles generation and reduce the concentration of estradiol in the periods of peak luteinizing hormone drug can make the follicle delayed crack 5 ~ 9 days
Early luteal administration did not significantly delay endometrial maturation, but reduced endometrial thickness by 0.62.2 mm(mean SD)
You Might Also Like
Oil-Lubricated Rotary Vane Vacuum Pump for Automotive Tanks
2.7mm Wire Galfan Wire Hexagonal Gabion Box Network Grid Mes......
Chinese Arabica Coffee Beans Yunnan Origin Coffee Beans
in Stock Bt136-600e/L01, 127 Thyristor Triac Logic - Sensiti......
High Efficiency and Environmental Protection Solution Regene......
China Yx76 -344-688 Galvanized Steel Floor Decking Panel
Grc Gfrc Cladding Panels and Wall Customizable Design Durabl......
Cg03 Lead-Free Ceramic Vape Cartridge with Custom Logo
50kHz Ultrasonic Transducer Distance Measurement for Ultraso......
Single Jet Water Meter (D7-8+1-2)
Popular 3D Wood Grain WPC Floor/ WPC Horrow Flooring